PHASE-I AND PHASE-II TRIAL OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-META-ANISIDIDE IN PATIENTS WITH ACUTE-LEUKEMIA

被引：0
|
作者：
ARLIN, ZA [1 ]
SKLAROFF, RB [1 ]
GEE, TS [1 ]
KEMPIN, SJ [1 ]
HOWARD, J [1 ]
CLARKSON, BD [1 ]
YOUNG, CW [1 ]
机构：
[1] MEM SLOAN KETTERING CANC CTR,DEPT MED,DEV CHEMOTHERAPY SERV,NEW YORK,NY 10021
来源：
CANCER RESEARCH | 1980年 / 40卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3304 / 3306
页数：3
相关论文
共 50 条
  • [31] PHASE-II CLINICAL-EVALUATION OF INTRAVENOUS 4'-(9-ACRIDINYLAMINO) METHANESULFON-M-ANISIDIDE IN COLORECTAL-CANCER
    VALDIVIESO, M
    STROEHLEIN, JR
    BEDIKIAN, AY
    KARLIN, DA
    LEGHA, SS
    BENNETTS, RW
    BODEY, GP
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (01): : 39 - 44
  • [32] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-META-ANISIDIDE IN PLASMA
    JURLINA, JL
    PAXTON, JW
    JOURNAL OF CHROMATOGRAPHY, 1983, 276 (02): : 367 - 374
  • [33] PHASE II TRIAL OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-M-ANISIDIDE (AMSA) IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
    VANECHO, DA
    MARKUS, S
    AISNER, J
    WIERNIK, PH
    CANCER TREATMENT REPORTS, 1980, 64 (8-9): : 1009 - 1010
  • [34] IDENTIFICATION OF THE ACTIVE SPECIES IN DEOXYRIBONUCLEIC-ACID BREAKAGE INDUCED BY 4'-(9-ACRIDINYLAMINO)METHANESULFON-META-ANISIDIDE AND COPPER
    WONG, A
    CHENG, HY
    CROOKE, ST
    BIOCHEMICAL PHARMACOLOGY, 1986, 35 (07) : 1071 - 1078
  • [35] DNA LESIONS AND CYTO-TOXICITY BY 4'-(9-ACRIDINYLAMINO) METHANESULFON-META-ANISIDIDE (META-AMSA) AND ADRIAMYCIN (ADR)
    ZWELLING, L
    MICHAELS, S
    ERICKSON, L
    ROSS, W
    NICHOLS, M
    STEREN, A
    JUDE, G
    KOHN, K
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 230 - 230
  • [36] A PHASE-I AND PHASE-II STUDY OF META-AMSA IN ACUTE-LEUKEMIA
    SLEVIN, ML
    SHANNON, MS
    PRENTICE, HG
    GOLDMAN, AJ
    LISTER, TA
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1981, 6 (02) : 137 - 140
  • [37] PHASE-II EVALUATION OF META-AMSA (4'-(9-ACRIDINYLAMINO)-METHANE-SULFON-META-ANISIDIDE) IN PATIENTS WITH ADENOCARCINOMA OF THE PANCREAS
    STERNBERG, CN
    MAGILL, GB
    SORDILLO, PP
    CHENG, E
    CURRIE, VE
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (04): : 459 - 462
  • [38] TREATMENT OF ACUTE-LEUKEMIA IN RELAPSE WITH 4'(9-ACRIDINYLAMINO) METHANESULFON-M-ANISIDIDE (ASMA) IN COMBINATION WITH CYTOSINE-ARABINOSIDE AND THIOGUANINE
    ARLIN, ZA
    FLOMENBERG, N
    GEE, TS
    KEMPIN, SJ
    DELLAQUILA, C
    MERTELSMANN, R
    STRAUS, DJ
    YOUNG, CW
    CLARKSON, RD
    CANCER CLINICAL TRIALS, 1981, 4 (03) : 317 - 321
  • [39] PHASE-II STUDY OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-M-ANISIDIDE (AMSA) IN OVARIAN-CARCINOMA, HYPER-NEPHROMA, AND MELANOMA
    AMREIN, PC
    POULIN, RF
    RICHARDS, F
    CAREY, RW
    COLEMAN, M
    RAFLA, S
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 531 - 531
  • [40] MECHANISM OF ANTITUMOR DRUG-ACTION - POISONING OF MAMMALIAN DNA TOPOISOMERASE-II ON DNA BY 4'-(9-ACRIDINYLAMINO)-METHANESULFON-META-ANISIDIDE
    NELSON, EM
    TEWEY, KM
    LIU, LF
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (05): : 1361 - 1365
12345